The first patients have been dosed in a phase 3 trial of an mRNA-based seasonal influenza vaccine developed ... should also reach the clinic this year. Sanofi has reported positive results a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback